Clinical manifestations of the anti‐phospholipid syndrome as defined by the updated Sapporo classification criteria
AUTOR(ES)
Drijkoningen, Jesse
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1994325Documentos Relacionados
- Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.
- Assessment of the 2006 revised antiphospholipid syndrome classification criteria
- Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro.
- Anti-phospholipid syndrome in seven leprosy patients with thrombotic events on corticosteroid and/or thalidomide regimen: insights on genetic and laboratory profiles
- Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus.